Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab

SARS-CoV-2 accesses host cells via angiotensin-converting enzyme-2, which is also affected by commonly used angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), raising concerns that ACEI or ARB exposure may portend differential COVID-19 outcomes. In parallel co...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Steven M., Desai, Raj A., Walsh, Marta G., Nilles, Ester Kim, Shaw, Katie, Smith, Myra, Chamberlain, Alanna M., Derington, Catherine G., Bress, Adam P., Chuang, Cynthia H., Ford, Daniel E., Taylor, Bradley W., Chandaka, Sravani, Patel, Lav Parshottambhai, McClay, James, Priest, Elisa, Fuloria, Jyotsna, Doshi, Kruti, Ahmad, Faraz S., Viera, Anthony J., Faulkner, Madelaine, O'Brien, Emily C., Pletcher, Mark J., Cooper-DeHoff, Rhonda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889730/
https://www.ncbi.nlm.nih.gov/pubmed/35252907
http://dx.doi.org/10.1016/j.ahjo.2022.100112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889730/
https://www.ncbi.nlm.nih.gov/pubmed/35252907
http://dx.doi.org/10.1016/j.ahjo.2022.100112

Ejemplares similares